1. Academic Validation
  2. [Pharmacological parameters of muscarinic cholinoreceptors in skeletal muscles]

[Pharmacological parameters of muscarinic cholinoreceptors in skeletal muscles]

  • Ross Fiziol Zh Im I M Sechenova. 2002 May;88(5):619-26.
N V Naumenko 1 A I Malomuzh R A Khairova A L Zefirov A Kh Urazaev
Affiliations

Affiliation

  • 1 Kazan State Medical University, 420012, Kazan, 49 Butlerov St., Russia.
PMID: 12136730
Abstract

It has been shown that bath application of muscarine delayed the early post-denervation depolarization in the muscle fibers incubated for 3 h in culture medium. The greatest reduction of the post-devervation depolarization was observed with 50 nmol/l muscarine. Atropine, a muscarinic antagonist, clozapine, a specific inhibitor of M1/M5-cholinergic receptors, and nitrocaramiphen, a M1-antagonist, completely removed the hyperpolarizing effect of muscarine. 4-DAMP, a specific inhibitor of M3-cholinergic receptors, himbacine, an antagonist of M2-cholinergic receptors, and tropicamide, a specific inhibitor of M2/M4-cholinergic receptors, failed to prevent the effect of muscarine. A M1/M2 muscarine agonists propargyl and but-2-ynyl esters of arecaidine had apparent muscarine-like effect. Nitrocaramiphen, and not himbacine, prevented the hyperpolarizing effect of these cholinomimetics. It is concluded that muscarine and esters of arecaidine delay the development of early postdenervation depolarization in M1-cholinergic receptors of skeletal muscle.

Figures
Products